Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
4/5 12:45
Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than quadrupling and Novo's shares more than tripling over the last three years....